Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087497958> ?p ?o ?g. }
- W3087497958 endingPage "e001229" @default.
- W3087497958 startingPage "e001229" @default.
- W3087497958 abstract "Background C-type lectin-like molecule 1 (CLL-1) is highly expressed in acute myeloid leukemia (AML) but is absent in primitive hematopoietic progenitors, making it an attractive target for a chimeric antigen receptor (CAR) T-cell therapy. Here, we optimized our CLL-1 CAR for anti-leukemic activity in mouse xenograft models of aggressive AML. Methods First, we optimized the CLL-1 CAR using different spacer, transmembrane and costimulatory sequences. We used a second retroviral vector to coexpress transgenic IL15. We measured the effects of each construct on T cell phenotype and sequential (recursive) co culture assays with tumor cell targets to determine the durability of the anti tumor activity by flow cytometry. We administered CAR T cells to mice engrafted with patient derived xenografts (PDX) and AML cell line and determined anti tumor activity by bioluminescence imaging and weekly bleeding, measured serum cytokines by multiplex analysis. After euthanasia, we examined formalin-fixed/paraffin embedded sections. Unpaired two-tailed Student’s t-tests were used and values of p<0.05 were considered significant. Survival was calculated using Mantel-Cox log-rank test. Results In vitro, CLL-1 CAR T cells with interleukin-15 (IL15) were less terminally differentiated (p<0.0001) and had superior expansion compared with CD28z-CD8 CAR T cells without IL15 (p<0.001). In both AML PDX and AML cell line animal models, CLL-1 CAR T coexpressing transgenic IL15 initially expanded better than CD28z-CD8 CAR T without IL15 (p<0.0001), but produced severe acute toxicity associated with high level production of human tumor necrosis factor α (TNFα), IL15 and IL2. Histopathology showed marked inflammatory changes with tissue damage in lung and liver. This acute toxicity could be managed by two strategies, individually or in combination. The excessive TNF alpha secretion could be blocked with anti-TNF alpha antibody, while excessive T cell expansion could be arrested by activation of an inducible caspase nine safety switch by administration of dimerizing drug. Both strategies successfully prolonged tumor-free survival. Conclusion Combinatorial treatment with a TNFα blocking antibody and subsequent activation of the caspase-9 control switch increased the expansion, survival and antileukemic potency of CLL-1 CAR T-cells expressing transgenic IL15 while avoiding the toxicities associated with excessive cytokine production and long-term accumulation of activated T-cells." @default.
- W3087497958 created "2020-09-25" @default.
- W3087497958 creator A5005166350 @default.
- W3087497958 creator A5012690337 @default.
- W3087497958 creator A5020421446 @default.
- W3087497958 creator A5021029688 @default.
- W3087497958 creator A5046750921 @default.
- W3087497958 creator A5058287032 @default.
- W3087497958 creator A5068501408 @default.
- W3087497958 creator A5074956754 @default.
- W3087497958 creator A5075645665 @default.
- W3087497958 creator A5081218567 @default.
- W3087497958 creator A5084741818 @default.
- W3087497958 creator A5086415382 @default.
- W3087497958 creator A5088976238 @default.
- W3087497958 date "2020-09-01" @default.
- W3087497958 modified "2023-10-15" @default.
- W3087497958 title "Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia" @default.
- W3087497958 cites W1584994624 @default.
- W3087497958 cites W1685882185 @default.
- W3087497958 cites W1930470734 @default.
- W3087497958 cites W1972188754 @default.
- W3087497958 cites W1975962380 @default.
- W3087497958 cites W1976262436 @default.
- W3087497958 cites W1989273697 @default.
- W3087497958 cites W1991427076 @default.
- W3087497958 cites W2003197307 @default.
- W3087497958 cites W2006027051 @default.
- W3087497958 cites W2014751400 @default.
- W3087497958 cites W2032396826 @default.
- W3087497958 cites W2033210035 @default.
- W3087497958 cites W2070770310 @default.
- W3087497958 cites W2072857434 @default.
- W3087497958 cites W2075901463 @default.
- W3087497958 cites W2076560655 @default.
- W3087497958 cites W2082708772 @default.
- W3087497958 cites W2093762704 @default.
- W3087497958 cites W2095433065 @default.
- W3087497958 cites W2097175022 @default.
- W3087497958 cites W2113753666 @default.
- W3087497958 cites W2119222271 @default.
- W3087497958 cites W2122465970 @default.
- W3087497958 cites W2145985838 @default.
- W3087497958 cites W2151673496 @default.
- W3087497958 cites W2154746915 @default.
- W3087497958 cites W2164364292 @default.
- W3087497958 cites W2340435799 @default.
- W3087497958 cites W2617490000 @default.
- W3087497958 cites W2621998980 @default.
- W3087497958 cites W2738977754 @default.
- W3087497958 cites W2758011629 @default.
- W3087497958 cites W2761657464 @default.
- W3087497958 cites W2761903029 @default.
- W3087497958 cites W2802646364 @default.
- W3087497958 cites W2898794856 @default.
- W3087497958 cites W2905654445 @default.
- W3087497958 cites W2917664072 @default.
- W3087497958 cites W2921450513 @default.
- W3087497958 cites W2924478881 @default.
- W3087497958 cites W2947566808 @default.
- W3087497958 cites W2950263975 @default.
- W3087497958 cites W2950581734 @default.
- W3087497958 cites W2952260713 @default.
- W3087497958 cites W2999031113 @default.
- W3087497958 cites W3004611567 @default.
- W3087497958 cites W3008202299 @default.
- W3087497958 cites W3008284415 @default.
- W3087497958 cites W3015696390 @default.
- W3087497958 doi "https://doi.org/10.1136/jitc-2020-001229" @default.
- W3087497958 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7497527" @default.
- W3087497958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32938629" @default.
- W3087497958 hasPublicationYear "2020" @default.
- W3087497958 type Work @default.
- W3087497958 sameAs 3087497958 @default.
- W3087497958 citedByCount "24" @default.
- W3087497958 countsByYear W30874979582021 @default.
- W3087497958 countsByYear W30874979582022 @default.
- W3087497958 countsByYear W30874979582023 @default.
- W3087497958 crossrefType "journal-article" @default.
- W3087497958 hasAuthorship W3087497958A5005166350 @default.
- W3087497958 hasAuthorship W3087497958A5012690337 @default.
- W3087497958 hasAuthorship W3087497958A5020421446 @default.
- W3087497958 hasAuthorship W3087497958A5021029688 @default.
- W3087497958 hasAuthorship W3087497958A5046750921 @default.
- W3087497958 hasAuthorship W3087497958A5058287032 @default.
- W3087497958 hasAuthorship W3087497958A5068501408 @default.
- W3087497958 hasAuthorship W3087497958A5074956754 @default.
- W3087497958 hasAuthorship W3087497958A5075645665 @default.
- W3087497958 hasAuthorship W3087497958A5081218567 @default.
- W3087497958 hasAuthorship W3087497958A5084741818 @default.
- W3087497958 hasAuthorship W3087497958A5086415382 @default.
- W3087497958 hasAuthorship W3087497958A5088976238 @default.
- W3087497958 hasBestOaLocation W30874979581 @default.
- W3087497958 hasConcept C147483822 @default.
- W3087497958 hasConcept C153911025 @default.
- W3087497958 hasConcept C154317977 @default.
- W3087497958 hasConcept C167672396 @default.
- W3087497958 hasConcept C202751555 @default.